CePower GmbH - Company Review
SummaryCePower GmbH - Company Review
Summary
CePower GmbH (CePower) is a developer and manufacturer of monoclonal antibodies. The company’s technology include development of hybridoma cells, immunization of mice and titre monitoring, isolation and cryoconservation of spleen cells from immunized mice, fusion of spleen cells from one mice with a myeloma cell line, screening and isolation the positive clones by elisa method, subcloning, and others. It utilizes celline, a disposable bioreactor for the production and purification of monoclonal antibodies. The company operates as a member of the Swiss Biotech Association. CePower is headquartered in Wadenswil, Switzerland.
This comprehensive company report of CePower GmbH provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.